SELLAS Life Sciences Group, Inc. SLS Short- and long-term operating lease liabilities
Short- and long-term operating lease liabilities at other companies
Other financials
Where this comes from
Reported directly by SELLAS Life Sciences Group, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOperatingLeaseLiability.
The official record: SELLAS Life Sciences Group, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about SELLAS Life Sciences Group, Inc.'s short- and long-term operating lease liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is SELLAS Life Sciences Group, Inc.'s short- and long-term operating lease liabilities?
- SELLAS Life Sciences Group, Inc. (SLS) reported short- and long-term operating lease liabilities of -$159K in Q1 2026.
- How has SELLAS Life Sciences Group, Inc.'s short- and long-term operating lease liabilities changed year-over-year?
- SELLAS Life Sciences Group, Inc.'s short- and long-term operating lease liabilities decreased by 0.0% year-over-year, from -$159K to -$159K.
- What is the long-term trend for SELLAS Life Sciences Group, Inc.'s short- and long-term operating lease liabilities?
- Over 3 years (2022 to 2025), SELLAS Life Sciences Group, Inc.'s short- and long-term operating lease liabilities has grown at a 10.5% compound annual growth rate (CAGR), from -$471K to -$635K.